Continuous Glucose Monitoring for Diabetes
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests the effectiveness of continuous glucose monitoring (CGM) in managing type 2 diabetes. It focuses on individuals who take at least one insulin shot daily and are either uninsured or have Medicaid. Participants will either use a CGM device or continue with regular self-monitoring methods. The researchers aim to determine if CGM can improve care in communities that often face healthcare challenges. Ideal candidates for this trial have type 2 diabetes, regularly take insulin, and encounter difficulties accessing regular healthcare. As an unphased trial, this study provides an opportunity to contribute to research that could enhance diabetes management for underserved communities.
Do I have to stop taking my current medications for the trial?
The trial information does not specify if you need to stop taking your current medications. However, since the study involves participants who are already taking insulin, it seems likely that you will continue your insulin therapy.
What prior data suggests that continuous glucose monitoring is safe for diabetes management?
Research has shown that continuous glucose monitoring (CGM) is safe for people with diabetes. Studies indicate that CGM helps individuals maintain stable blood sugar levels and manage their diabetes more effectively. No major safety concerns have been reported, indicating that CGM is generally well-tolerated. Many people with diabetes already use CGM, further supporting its safety. Overall, CGM serves as a reliable tool in diabetes care.12345
Why are researchers excited about this trial?
Researchers are excited about Continuous Glucose Monitoring (CGM) for diabetes because it offers a real-time, dynamic picture of glucose levels, unlike traditional methods like fingerstick blood tests. CGM devices continuously track glucose levels throughout the day and night, providing insights into trends and patterns that standard self-monitoring can't capture. This can help people with diabetes make more informed decisions about diet, exercise, and medication, potentially leading to better blood sugar control and a reduced risk of complications. Additionally, the convenience of not having to perform multiple finger pricks daily is a significant improvement in quality of life for many patients.
What evidence suggests that continuous glucose monitoring is effective for diabetes?
Research has shown that Continuous Glucose Monitoring (CGM), which participants in this trial may receive, can help people with diabetes manage their condition more effectively. Studies have found that CGM slightly lowers HbA1c levels, an important measure of blood sugar control, by about 0.32%. Users of CGM often experience improvements in their "time in range," meaning the percentage of time their blood sugar stays within the target range. Specifically, one study noted an increase from 39.7% to 61.9%. Additionally, CGM users report greater satisfaction with their diabetes management. These findings suggest that CGM can significantly enhance blood sugar control and overall diabetes management.45678
Who Is on the Research Team?
Shaveta Gupta, MD
Principal Investigator
Tulane University
Are You a Good Fit for This Trial?
This trial is for people with Type 2 Diabetes who are uninsured or on Medicaid and take insulin injections daily. It's aimed at helping those in underserved communities. The goal is to see if using Continuous Glucose Monitoring (CGM) can improve their health care.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Run-in
Participants undergo a two-week run-in period before randomization
Treatment
Participants are randomized to either continuous glucose monitoring or self-monitoring of blood glucose for 6 months
Follow-up
Participants are monitored for changes in HbA1c and other outcomes
Optional Follow-up
Participants in the self-monitoring group may opt to wear the CGM sensor for an additional 3 months
What Are the Treatments Tested in This Trial?
Interventions
- Continuous Glucose Monitoring (CGM)
Trial Overview
The study tests whether Continuous Glucose Monitoring (CGM) devices help manage diabetes better in an underserved population. Participants will be randomly chosen to either use CGM or continue their usual care, as a pilot before a larger study.
How Is the Trial Designed?
The study participants will be randomized to the continuous glucose monitoring group (intervention).
The study participants will be randomized to the self-monitoring group (control) after a period of two-week run-in and followed for 6 months. They will be given an opportunity to wear the CGM sensor for 3 months at the conclusion of the 6-month follow-up as an optional follow-up.
Find a Clinic Near You
Who Is Running the Clinical Trial?
Tulane University
Lead Sponsor
Abbott
Industry Sponsor
Dr. Etahn Korngold
Abbott
Chief Medical Officer
MD, Harvard Medical School
Robert B. Ford
Abbott
Chief Executive Officer since 2020
Bachelor's degree from Boston College, MBA from UC Berkeley, Haas School of Business
Citations
Effectiveness of Continuous Glucose Monitoring on Metrics ...
Moderate certainty of evidence indicated that use of CGM had a modest but statistically significant reduction in HbA1c levels of about 0.32%.
2.
diabetesjournals.org
diabetesjournals.org/care/article/48/9/1581/163057/Real-Time-Continuous-Glucose-Monitoring-inReal-Time Continuous Glucose Monitoring in Pregnancies ...
We demonstrated a significantly higher %TIR using real-time CGM compared with CBG glucose monitoring among pregnant people with GDM. Studies are ...
Advances in Continuous Glucose Monitoring: Clinical ...
Studies show that people with diabetes (PwD) using CGM achieve better glycemic outcomes and greater satisfaction with their diabetes management.
Using continuous glucose monitoring to measure and ...
EFFICACY AND UTILITY OF CGM ... Other studies have demonstrated that CGM use significantly enhances users' understanding of their diabetes and ...
Continuous glucose monitoring among adults with type 2 ...
Patients showed improvements in time in range (39.7–61.9%, p < 0.0001), time > 180 mg/dL (60.1–37.9%, p < 0.001), time > 250 mg/dL (27.6–8.5%, p ...
Effects of CGM on Glycemic Control in Type 2 Diabetes
The results of this study showed that intervention using CGM was effective in reducing HbA1c in type 2 diabetes.
7.
diabetesjournals.org
diabetesjournals.org/care/article/47/1/169/154009/Efficacy-and-Safety-of-Continuous-GlucoseEfficacy & Safety of CGM in Type 2 Diabetes: Review
Both CGM and isCGM demonstrated a reduction in HbA 1c levels in individuals with T2D, and unlike CGM, isCGM use was associated with improved user satisfaction.
Continuous Glucose Monitoring (CGM)
Real-time continuous glucose monitoring has led to tremendous outcomes for people with diabetes who, without a CGM, may have experienced potentially life- ...
Other People Viewed
By Subject
By Trial
Related Searches
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.